Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by SizzlinSteakson Jun 11, 2018 12:15pm

109 Views

Post# 28154719

RE:RE:RE:RE:RE:RE:RE:Lets see that big Pharma partner announcement please...!

Yes, but again we are on the venture with a very limitted audience. Until it gets headline news, there are few new investors seeing this outside the current group of investors. We need our headlines to start hitting mainstream media. I sure hope that happens with the 120 day results on patients #5 & #6.

bencro wrote: SizzlinSteaks ... Past market reactions would not be much of an issue as this time, P#5 and P#6 data would be human data and so, be able to put things into perspectives compared to current standards of care. That's the BIG difference, versus when we were into pre-clinical data only. This would allow the market to see where we can fit in the mid-term horizon.

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue